Posted by Michael Wonder on 23 May 2018
Trump’s plan won’t lower prescription drug prices. Ours would.
23 May 2018 - The White House is pushing half-measures. We need more.
The drug price reforms that President Trump recently proposed are as potent as a placebo, but not as harmless.
Trump once blustered that drug firms were “getting away with murder,” but his real-life plan caused pharmaceutical stocks to surge as investors foresaw even higher prices and profits ahead. The president stepped away from his earlier promises to allow Medicare to negotiate prices, while vowing to fight for higher drug prices abroad — a gold mine for the industry that would do nothing to reduce drug prices at home.
